Gender Dysphoria and Transition

Gender Dysphoria Clinical Trial

— DyGePeT  

Official title:

Gender Dysphoria and Transition: Testimony From Transgender People

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04265885
• Other study ID #: 2020PI033
• Status: Not yet recruiting
• Start date: October 2020
• Est. completion date: September 2021

Study information

• Verified date: July 2020
• Source: Central Hospital, Nancy, France
• Contact: Eva Feigerlova, MD, PhD
• Phone: +33(0)83155032
• Email: e.feigerlova[@]chru-nancy.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Persons with gender dysphoria present the difficulties of access to health care. Little time is devoted to education of health professionals about the care of transgender persons. According to the proposal of the French Ministry of Social Affairs and Health there is a need to increase knowledge in this area and to improve the care of transgender people including prevention and screening.

Similarly, little is known about social and medical needs of the transgender population.

This project proposes to illustrate gender dysphoria through testimonies of transgender people with the aim to increase the investigator's understanding aout the needs and the desires of this population and to describe the process of medical and social transition.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 10
• Est. completion date: September 2021
• Est. primary completion date: June 2021
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Person affiliated to a social security system

• Person having received complete information on the organisation of the research and having signed the informed consent

• Person having carried out a prior clinical examination adapted to the research

• Age> 18 years

• Diagnosis of gender incongruence (dysphoria) according to the international classification of diseases, revision 11

Exclusion Criteria:

• Severe, uncontrolled psychiatric or somatic illness

• Substance and alcohol addiction

• Pregnancy

Related Conditions & MeSH terms

• Depressive Disorder, Major
• Gender Dysphoria

Intervention

Other:
• collection of testimonies from transgender people
guided interview

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France	University of Lorraine

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Illustrate the real-life experiences of transgender people		4 months